Design, Synthesis and Evaluation of Functionalized Azaglycinamides as Cytotoxic and Antinociceptive Agents Functionalized Azaglycinamides as Cytotoxic and Antinociceptive Agents
Iranian Journal of Pharmaceutical Sciences,
دوره 17 شماره 2 (2021),
1 فروردین 2021
,
صفحه 129-158
https://doi.org/10.22037/ijps.v17.40291
چکیده
Aza analogs of peptides are used in the treatment of cancer and neurodegenerative disorders. The clinical approval of goserelin for the treatment of prostate cancer proves the therapeutic potentiality of azaglycine residue. With this background, a novel approach to functionalizing the azaglycine moiety aimed at compounds possessing C-functionalization with active five membered heterocycles (pyrrole, imidazole, etc thiazolidine-2, 4-dione) and N-functionalization with acyl chains on azaglycine moiety were synthesized. The compounds were evaluated for in vitro MAGL inhibition and cytotoxicity against MCF-7 cell lines. The biological activities were corroborated with molecular docking studies with Cathepsin B and MAGL enzymes. The compounds with prominent in vitro and in silico potential against MAGL were evaluated for antinociceptive activity. This privileged N- and C-functionalization approach in the synthesis of azaglycinyl analogs demonstrated that N-oleoyl and C-thiazolidine-2,4-dione functionalized azaglycinamide derivative 1q, was found to possess moderate cytotoxic and MAGL inhibitory profile. The active compounds were well accommodated in the binding sites of these targets with good electrostatic complementarity. The N-oleoyl and C-thiazolidine-2, 4-dione functionalized azaglycine can be envisaged as a novel molecule with potential anticancer and antinociceptive activities.
- Azaglycinamides
- N- and C- functionalization
- MAGL Inhibition
- Antinociception
- Cytotoxicity
ارجاع به مقاله
مراجع
[2] Avan I, Hall CD and Katritzky AR. Peptidomimetics via Modifications of Amino acids and Peptide Bonds. Chem. Soc. Rev. (2014)43:3575-3594.
[3] Zega A. Azapeptides as Pharmacological Agents. Curr. Med. Chem. (2004)12:589-597.
[4] Lv Z, Chu Y and Wang Y. HIV Protease Inhibitors: A Review of Molecular Selectivity and Toxicity. HIV/AIDS – Res. Palliat. Care. (2015)95–104.
[5] Kurian LA, Silva T A and Sabatino D Submonomer Synthesis of Azapeptide Ligands of the Insulin Receptor Tyrosine Kinase Domain. Bioorg. Med.Chem. Lett. (2014)24:4176-4180.
[6] Loser R, Frizler M, Schilling K and Gutschow M. Azadipeptide Nitriles: Highly Potent and Proteolytically Stable Inhibitors of Papain-like Cysteine Proteases. Chem. Int. Ed. (2008) 47:4331-4334.
[7] Dinh TP, Carpenter D, Leslie FM, Freund TF, Katona I and Sensi SL. Brain Monoglyceride Lipase Participating in Endocannabinoid Inactivation. Proc. Natl. Acad. sci. USA (2002)99:10819-10824.
[8] Alpizar YA, Gees M, Sanchez A, Apetrei A, Voets T, Nilius Band Talavera K. Bimodal Effects of Cinnamaldehyde and Camphor on Mouse TRPA1. Pflug. Archiv. (2013)465:853–864.
[9] Walter H. New Carboxylic Acid Amides of the Pyrrole Series: Synthetic Routes and Biological Aspects.Z. Naturforsch. (2008) 63:351 – 362.
[10] Petit S, Fruit CandBischoff L. New Family of Peptidomimetics Based on the Imidazole Motif. Org. Lett. (2010)12:4928-4931.
[11] Apotrosoaei M, Vasincu I, Constantin S, Buron F, Routier S and Profire L. Synthesis, Characterization and Antioxidant Activity of Some New Thiazolidin-4-one Derivatives. Rev. Med. Chir. Soc. Med. Nat. Iasi. (2014)18:213-218.
[12] Carpenter CA, Kenar JA and Price NPJ. Preparation of Saturated and Unsaturated Fatty Acid Hydrazides and Long Chian C-glycoside ketohydrazones. Green Chem. (2020)12:2012-2018.
[13] Celine S. Crystal Structure of a Soluble form of Human Monoglycerol Lipase in Complex with an Inhibitor at 1.35 A resolution Protein sci. (2011)20:670-683.
[14] Prashanthi G, Prasad KVSRG and Bharathi K. Design, Synthesis and Evaluation of dialkyl 4-(benzo[d][1,3]dioxol-6-yl)-1,4-dihydro-2,6-dimethyl-1-substitutedpyridine-3,5-dicarboxylates as Potential Anticonvulsants and their Molecular Properties Prediction. Eur.J.Med.Chem. (2013)66:516.
[15] Eddy NB and Leimbach D. Synthetic Analgesic II. Dithienylbutenyl and Dithienylbutylamines. J. Pharmacol. Exp. Ther. (1953)107:385–393.
[16] Muccioli GG, Geoffrey Labar and Lambert MD. CAY10499, A Novel Monoglyceride Lipase Inhibitor Evidenced by an Expeditious MGL Assay. Chem. Bio. Chem. (2008)9:2704-2710.
[17] Cheese right T, Mackey M, Rose S and Vinter A. Molecular Field Extrema as Descriptors of Biological Activity: Definition and Validation. J. Chem. Inf. Model. (2006) 46:665–676.
[18] Score VS. Docking Factor-Xa ligands with Lead Finder- Case Study.T. C. a. f. u. software [online] (2016). Available from: https://www.cresset-group.com/tag/lead-finder.
[19] Dixon WJ. Staircase Bioassay: The Up -and-Down Method. Neurosci. Biobehav. Rev. (1995)15:47-50.
[20] Haseena banu B, Prasad KVSRG and Bharathi K. Synthesis and Biological Evaluation of N-dehydrodipeptidyl-N,N’-dicyclohexylurea Analogs. Eur. J. Med. Chem. (2014)78:72-85.
[21] Rajitha G, Prasad KandBharathi K. Synthesis and Biological Evaluation of 3-Amino Pyrazolones. Asian J. Chem. (2011)23:684-686.
[22] Nakamura Y, Une Y, Miyano K, Abe H, Hisaoka K, Morioka N and Nakata Y. Activation of Transient Receptor Potential Ankyrin 1 Evokes Nociception through Substance P Release from Primary Sensory Neurons. J. Neurochem. (2012)120:1036-1047.
[23] Sun. 4-(2-Pyridyl) piperazine-1-carboxamides: Potent Vanilloid Receptor 1 Antagonists. Bioorg. Med. Chem. Lett. (2003)13:3611–3616.
[24] Pinheiro DS, Junior ENS and Consolini G. Optimized Synthesis and Characterization of Thiazolidine-2, 4-dione for Pharmaceutical Application. J. Biorg. Org. Chem. (2017)1:122‒126.
[25] Gray MD, Jeschsa SA and Stein GH. 5-Azacytidine-Induced Demethylation of DNA to Senescent Level does not Block Proliferation of Human Fibroblasts. J. Cell. Physiol. (1991)8:477-484.
[26] Lbachir Ben Mohamed, Radhika Krishnan, Catherine Auge, James F. P and Don J D Intranasal Administration of a Synthetic Lipopeptide Without Adjuvant Induces Systemic Immune Responses, Immunology (2002)106:113–121.
[27] Mishra G, Sachan N and Chawla P. Synthesis and Evaluation of Thiazolidinedione–Coumarin Adducts as Antidiabetic, Anti–Inflammatory and Antioxidant Agents. Letter in Org. Chem. (2015)12:429–445.
[28] Matej Sovaeljkoak, Jelena A, Samo Turk, Zorica DJ and Irena Mlinari Rascan Stanislav Gobec. Cinnamic Acid Derivatives Induce Cell Cycle Arrest in Carcinoma Cell Lines. Med. Chem. (2013) 11:9-15.
[29] Rea P, Jatta T, Olli E, Francisco RLP, Merja H and Juha OR. Monoacylglycerol Lipase Inhibitor JZL184 Reduces Neuroinflammatory Response in APdE9 Mice and in Adult Mouse Glial Cells. J. Neuroinflam. (2015) 12:81- 92.
[30] Matuzak N, Giulio G, Muccioli, Geoffrey Labar and Lambert MD. Synthesis and in Vitro Evaluation of N-Substituted Maleimide Derivatives as Selective Monoglyceride Lipase Inhibitors. J. Med. Chem. (2009) 52:7410–7420.
[31] Levenson AS and Jordan VC. MCF-7: The First Hormone-Responsive Breast Cancer Cell Line. Cancer Res. (1997) 57:3071-3078.
[32] Mohamed MM and Sloane BF. Cysteine cathepsins: Multifunctional Enzymes in Cancer. Nat. Rev. Cancer. (2006) 6:764-775.
[33] Zhou Z, Wang Y and Bryant SH. Multi-conformation 3D QSAR Study of Benzenesulfonyl-Pyrazol-ester Compounds and their Analogs as Cathepsin B Inhibitors. J. Mol.Graph.Model. (2011) 30:135-147.
[34] Izabela P and Bonnie FS. Cathepsin B and its role in Cancer Progression. Biochem. Soc. Symp. (2003)70:263-276.
[35] Wieczerzak E, Jamkowska S, Rodziewicz-Motowidlo A, Gieldon J, Lagiewka Z, Grzonka M, Abrahamson A, Grubb A and Bromme D. Novel Azapeptide Inhibitorsof Cathepsins B and K. Structural Background to Increased Specificity for Cathepsin B. The J. Pept. Res. (2005) 66:1–11.
[36] Celine SH. Crystal Structure of a Soluble form of Human Monoglycerol Lipase in Complex with an Inhibitor at 1.35 A resolution. Protein sci. (2011) 20:670-683.
[37] Zhang Y, Malamakal RM and Chenoweth DM. Aza-Glycine Induces Collagen Hyperstability. J. Am. Chem. Soc. (2015)137:12422-12425.
[38] Laudelina RM. Activity Anti-Inflammatory and in silico Study of New Thiazolidinedione Derivatives. Brit. J. Pharm. Res. (2014) 4:1739-1752.
[39] Wongmayura A and Songkram C. (eds.) Synthesis and COX inhibitory activity of thiazole analogs derived from classical NSAIDs. Proceedings of the 6th Regional IMT-GT Uninet, Penang; (2008) Aug28-30; Malaysia.
[40] Brett Boonen, Justyna BS and Karel Talavera. Chemical Activation of Sensory TRP Channels. Topics in Med. Chem. New York Springer, (2016) 23:73–113.
- چکیده مشاهده شده: 76 بار
- IJPS_Volume 17_Issue 2_Pages 129-158 (English) دانلود شده: 25 بار